Physician Assistant · Houston, TX
NPI
1326481094
Since 2013
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,374
111 services
Medicare patients, 2024
73
Average age 70
Drug cost, 2024
$107K
210 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Meagan K McDowell was code 99233 (hospital e&m - subsequent), 52 times for 38 patients. In total Meagan K McDowell billed 111 services in 9 codes, and Medicare paid $7,374.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 52 | 38 | $73.16 | $3,804 |
| 99232 Hospital E&M - Subsequent | Facility | 19 | 18 | $47.40 | $901 |
By year: 2022 $31K for 446 services; 2023 $18K for 240 services; 2024 $7,374 for 111 services.
Medicare prescription drug claims, 2024
In 2024, the drug Meagan K McDowell prescribed most often to Medicare patients was Caspofungin Acetate, with 31 prescriptions and refills. In total Meagan K McDowell wrote 210 Medicare prescriptions that cost $107K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Caspofungin Acetate Generic | 31 | 31 | Under 11 | $15K |
| Daptomycin Generic | 29 | 29 | Under 11 | $16K |
| Ceftazidime Generic | 26 | 26 | Under 11 | $2,174 |
| Ertapenem Ertapenem Sodium | 24 | 24 | Under 11 | $6,808 |
| Amikacin Sulfate Generic | 13 | 13 | Under 11 | $396 |
Brand drugs: 24 claims; generic drugs: 186 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Meagan K McDowell were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.